Capital Markets

U.S. Equity: Steady as She Goes

Steady as She Goes for U.S. Equities
clock
2 min 27 sec

Despite concerns over the Trump administration’s ability to follow through on promises of lower taxes and decreased regulation, the market accelerated higher in the first quarter.

The S&P 500 Index hit a peak (2,396) in March and notched a 6.07% gain over the full three-month period. But the quarter was marked by reversals from the previous one—small cap fell behind large cap (Russell 2000 Index: +2.47% vs. Russell 1000 Index: +6.03%) and growth overtook value (Russell 1000 Growth Index: +8.91% vs. Russell 1000 Value Index: +3.27%).

The broader U.S. economy reflected the market’s optimism, and to no one’s surprise the Fed raised rates a quarter-point in mid-March. Wages continued to rise, consumer confidence was up, inflation moved closer to the 2% target, and unemployment fell to 4.7%. Yet some headwinds persisted in the U.S., with slowing GDP growth (the fourth quarter trailed the third, 2.1% vs. 3.5%), and significant issues abroad: elections and Brexit in Europe, the Syrian war in the Middle East, and South Korea’s presidential impeachment in Asia. Valuations in the U.S. remain high by various measures, but investors appear unfazed—for now.

Technology shares were especially strong; the FANG stocks—Facebook, Amazon, Netflix, and Google—hit record highs during the quarter. (Technically it should be the FANA stocks because Google is officially Alphabet—but FANG sounds better!) Micro and small cap companies ran out of steam after a strong 2016, while mid and large cap stocks charged ahead (Russell Microcap Index: +0.38%, Russell 2000 Index: +2.47%, Russell Midcap Index: +5.15%, and Russell 1000 Index: +6.03%). Value lost its lead over growth in all capitalizations (Russell 2000 Value Index: -0.13% vs. Russell 2000 Growth Index: +5.35%). The dispersion in style returns was broad across market capitalizations.

Rolling One-Year Relative Returns

Reflecting the reversal in investor preference, the best-performing sectors in the S&P 500 Index during the quarter were growth-oriented; Technology (+12.57%) was No. 1, followed by Consumer Discretionary (+8.45%), and Health Care (+8.37%). After leading in the fourth quarter, Financials (+2.53%) and Energy (-6.68%) trailed the broad market in the first. Both Health Care and Financials traded on President Donald Trump’s failure to amend the Affordable Care Act—Health Care stocks gained on the certainty of the status quo and Financials dropped on fear the administration may fall short on deregulation and tax reform as well. Energy was the worst-performing sector during the quarter as last year’s agreement by the Organization of the Petroleum Exporting Countries (OPEC) has not reduced fears of oversupply or meaningfully increased the price of oil.

As the U.S. equity market powered on, valuations across indices traded at historically high levels—the S&P 500 Index NTM (next 12 months) P/E was 17.5x versus the 25-year average of 14x as of March 31, 2017. Correlation (measured by S&P 500 stocks) ended the quarter below average and at levels not seen in 10 years, a positive for active management. Volatility (as measured by the CBOE Market Volatility Index, or VIX) also tracked below its average, seemingly unfazed by geopolitical uncertainty.

6.07%

The S&P 500 Index’s gain in the first quarter.

Posted by

Share
Share on facebook
Share on twitter
Share on linkedin
Related Posts
Macro Trends

Are Equity Returns More Volatile in an Election Year? It Depends!

Ric Ford
Two Callan experts assess how the 2024 election may affect stock returns by looking to history.
Public Markets

Stellar Markets Across Asset Classes

Kyle Fekete
Callan expert assesses the global markets in 3Q24 and the outlook heading into the election.
Public Markets

Navigating U.S. Equity Concentration: A Look at Global Stocks

Fanglue Zhou
Callan global ex-U.S. equities expert assesses U.S. equity concentration and opportunities outside the U.S.
Public Markets

The Supermicro Conundrum: When Successful Small Cap Stocks Hurt Managers

Nicole Wubbena
Callan expert analyzes the impact of Supermicro on small cap growth managers.
Public Markets

Gains for Stocks Mask Wide Disparities; Little to No Change for Bonds

Kristin Bradbury
Callan expert analyzes the global stock and bond markets in 2Q24.
Operations

A Deeper Look at How We Did With Our Capital Markets Assumptions

Julia Moriarty
An analysis of how Callan's Capital Markets Assumptions performed over time by asset class.
Public Markets

Is This a Time for Active Managers to Shine?

Tony Lissuzzo
A post from a member of the Callan Nonprofit Group on how dispersion affects active management.
Public Markets

Stocks Continue Rally; Bond Returns Fall Amid Rate Cut Uncertainty

Kristin Bradbury
Callan expert analyzes the performance of global markets in 1Q24 and the outlook for the year.
Public Markets

The Magnificent Seven and Large Cap Portfolios: What Institutional Investors Need to Know

Nicole Wubbena
What institutional investors need to know about the Magnificent Seven and large cap stock portfolios
Public Markets

Stocks Near a Record High, and Bonds Reverse Course

Kristin Bradbury
Kristin Bradbury analyzes global stock and bond markets in 4Q23.

Callan Family Office

You are now leaving Callan LLC’s website and going to Callan Family Office’s website. Callan Family Office is not affiliated with Callan LLC.  Callan LLC has licensed the Callan® trademark to Callan Family Office for use in providing investment advisory services to ultra-high net worth clients, family foundations, and endowments. Callan Family Office and Callan LLC are independent, unaffiliated investment advisory firms separately registered with the Securities and Exchange Commission under the Investment Advisers Act of 1940.

Callan LLC is not responsible for the services and content on Callan Family Office’s website. Inclusion of this link does not constitute or imply an endorsement, sponsorship, or recommendation by Callan LLC of their website, or its contents, and Callan LLC is not responsible or liable for your use of it. When visiting their website, you are subject to Callan Family Office’s terms of use and privacy policies.